Applied BioMath, LLC Announces Participation at the Cytokine-Based Cancer Immunotherapies Summit

CONCORD, Mass.: CONCORD, Mass., Nov. 29, 2021 /PRNewswire/ — Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at the Cytokine-Based Cancer Immunotherapies Summit occurring November 30th to December 2nd, 2021 in Boston, MA.
Click here to view original post